Spots Global Cancer Trial Database for who grade iii glioma
Every month we try and update this database with for who grade iii glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Targeted Pediatric High-Grade Glioma Therapy | NCT05839379 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Glioblastoma Glioblastoma Mu... Diffuse Midline... Metastatic Brai... WHO Grade III G... WHO Grade IV Gl... | 12 Months - 39 Years | Nationwide Children's Hospital | ||
| Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors | NCT04479696 | Glioblastoma WHO Grade II Gl... WHO Grade III G... | Educational Int... Questionnaire A... Survey Administ... Video | 18 Years - | M.D. Anderson Cancer Center | |
| Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers | NCT04630379 | Glioblastoma Malignant Gliom... WHO Grade III G... | Palliative Ther... Quality-of-Life... Supportive Care Survey Administ... | 18 Years - | Mayo Clinic | |
| Combination Therapy for the Treatment of Diffuse Midline Gliomas | NCT05009992 | Diffuse Intrins... Diffuse Midline... Recurrent Diffu... Recurrent Diffu... Recurrent WHO G... WHO Grade III G... | ONC201 Radiation Thera... Paxalisib | 2 Years - 39 Years | University of California, San Francisco | |
| Study of Ribociclib and Everolimus in HGG and DIPG | NCT05843253 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Glioblastoma Glioblastoma Mu... Diffuse Midline... Metastatic Brai... WHO Grade III G... WHO Grade IV Gl... | Ribociclib Everolimus | 12 Months - 39 Years | Nationwide Children's Hospital | |
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | NCT06333899 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Infant Type Hem... Glioblastoma Glioblastoma Mu... WHO Grade III G... WHO Grade IV Gl... Diffuse Midline... | Lorlatinib Lorlatinib with... Lorlatinib with... Lorlatinib post... | 1 Year - 21 Years | Nationwide Children's Hospital | |
| Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma | NCT04540107 | Recurrent World... Recurrent WHO G... WHO Grade II Gl... WHO Grade III G... | Hyperpolarized ... Magnetic Resona... Magnetic Resona... | 18 Years - | University of California, San Francisco | |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas | NCT04623931 | Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Diffuse Astrocy... Glioblastoma Oligoastrocytom... Oligodendroglio... WHO Grade II Gl... WHO Grade III G... | Quality-of-Life... Questionnaire A... Radiation Thera... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma | NCT01817751 | Glioblastoma Recurrent Adult... Malignant Gliom... WHO Grade III G... | sorafenib tosyl... valproic acid sildenafil citr... | 18 Years - | Virginia Commonwealth University | |
| Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors | NCT04479696 | Glioblastoma WHO Grade II Gl... WHO Grade III G... | Educational Int... Questionnaire A... Survey Administ... Video | 18 Years - | M.D. Anderson Cancer Center | |
| Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma | NCT03251027 | Glioblastoma WHO Grade II Gl... WHO Grade III G... | Intensity-Modul... Quality-of-Life | 18 Years - | Thomas Jefferson University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
